Approval · Notice of Compliance 8765 · 2007
SENSIPAR: Notice of Compliance 8765
Issued May 8, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8765
- Date
- May 8, 2007
- Company
- Amgen Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of monitoring instructions to the product monograph
- Therapeutic class
- Calcimimetic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SENSIPAR | Not yet assigned | — |
Medicinal ingredients
- CINACALCET HYDROCHLORIDE 30 MG per TAB
- CINACALCET HYDROCHLORIDE 60 MG per TAB
- CINACALCET HYDROCHLORIDE 90 MG per TAB